21 – 30 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2009
-
Mark
Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen.
(
- Contribution to journal › Article
- 2008
-
Mark
Oestrogen receptor beta immunohistochemistry: time to get it right? Authors' response
(
- Contribution to journal › Letter
-
Mark
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
(
- Contribution to journal › Article
- 2007
-
Mark
Hypoxia and breast cancer: prognostic and therapeutic implications
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer
(
- Contribution to journal › Article
-
Mark
Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
(
- Contribution to journal › Article
-
Mark
MTA1, a transcriptional activator of breast cancer amplified sequence 3
(
- Contribution to journal › Article
- 2005
-
Mark
Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome.
(
- Contribution to journal › Article
- 2004
-
Mark
Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »